Compile Data Set for Download or QSAR
Report error Found 1827 of affinity data for UniProtKB/TrEMBL: Q01726
TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250673(US9447148, 9.55 | US9447148, 9.42)
Affinity DataEC50:  0.00200nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250661(US9447148, 9.30)
Affinity DataEC50:  0.00200nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250673(US9447148, 9.55 | US9447148, 9.42)
Affinity DataEC50:  0.00200nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250668(US9447148, 9.50 | US9447148, 9.37)
Affinity DataEC50:  0.00300nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250649(US9447148, 9.18)
Affinity DataEC50:  0.00300nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250668(US9447148, 9.50 | US9447148, 9.37)
Affinity DataEC50:  0.00300nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250653(US9447148, 9.22)
Affinity DataEC50:  0.00400nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250651(US9447148, 9.20)
Affinity DataEC50:  0.00400nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250652(US9447148, 9.21)
Affinity DataEC50:  0.00400nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250648(US9447148, 9.17)
Affinity DataEC50:  0.00400nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250642(US9447148, 9.10)
Affinity DataEC50:  0.00400nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM50590037(CHEMBL5191309)
Affinity DataEC50:  0.00400nMAssay Description:Agonist activity at human MC1R expressed in HEK2936E cells assessed as cAMP production in presence of IBMX by time resolved fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
PubMed
TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM50033130((3R,6S,9R,12S,15S,23R)-15-((S)-2-Acetylamino-hexan...)
Affinity DataEC50:  0.00500nMAssay Description:Evaluated for agonist activity at cloned mammalian human MSH1 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2012
Entry Details Article
PubMed
TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM82411(CAS_75921-69-6 | NDP-MSH)
Affinity DataEC50:  0.00500nMAssay Description:Decrease in frog skin reflectivity (metabotropic activity).More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2012
Entry Details Article
PubMed
TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM50033130((3R,6S,9R,12S,15S,23R)-15-((S)-2-Acetylamino-hexan...)
Affinity DataEC50:  0.00500nMAssay Description:Evaluated for agonist activity against human Melanocortin 1 receptor using hMC1-R assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2012
Entry Details Article
PubMed
TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM135768(US8846601, 153 | US9458201, 153 | US10179804, Exam...)
Affinity DataEC50:  0.00500nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250661(US9447148, 9.30)
Affinity DataKi:  0.00500nM ΔG°:  -67.1kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250643(US9447148, 9.11)
Affinity DataEC50:  0.00500nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM50590042(CHEMBL5175981)
Affinity DataKi: >0.00549nMAssay Description:Displacement of [125I]-NDP-alpha-MSH from human MC1R expressed in HEK2936E cell membrane measured after 16 to 23 hrs by 1450 microbeta trilux scintil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
PubMed
TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250671(US9447148, 9.53 | US9447148, 9.40)
Affinity DataEC50:  0.00600nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250634(US9447148, 9.31 | US9447148, 9.2)
Affinity DataEC50:  0.00600nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM50131251((S)-5-Guanidino-2-{(S)-2-[(S)-3-(3H-imidazol-4-yl)...)
Affinity DataKi:  0.00600nMAssay Description:Binding affinity towards human Melanocortin 1 receptor (hMC1R)More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2012
Entry Details Article
PubMed
TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250660(US9447148, 9.29)
Affinity DataEC50:  0.00600nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250655(US9447148, 9.24)
Affinity DataEC50:  0.00600nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250671(US9447148, 9.53 | US9447148, 9.40)
Affinity DataEC50:  0.00600nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250654(US9447148, 9.23)
Affinity DataEC50:  0.00700nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250633(US9447148, 9.1)
Affinity DataEC50:  0.00700nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250659(US9447148, 9.28)
Affinity DataEC50:  0.00700nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250672(US9447148, 9.54 | US9447148, 9.41)
Affinity DataEC50:  0.00800nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250635(US9447148, 9.3)
Affinity DataEC50:  0.00800nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250641(US9447148, 9.9)
Affinity DataEC50:  0.00800nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250672(US9447148, 9.54 | US9447148, 9.41)
Affinity DataEC50:  0.00800nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM50131251((S)-5-Guanidino-2-{(S)-2-[(S)-3-(3H-imidazol-4-yl)...)
Affinity DataEC50:  0.00900nMAssay Description:In vitro agonist potency was evaluated in HEK293 cells transfected with human melanocortin receptor (hMC1R)More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2012
Entry Details Article
PubMed
TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM50152246((S)-5-Guanidino-2-((S)-2-{(S)-2-[(S)-3-(3H-imidazo...)
Affinity DataEC50:  0.00900nMAssay Description:Agonistic activity against human Melanocortin 1 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250658(US9447148, 9.27)
Affinity DataEC50:  0.00900nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM50590040(CHEMBL5185945)
Affinity DataEC50: <0.00900nMAssay Description:Agonist activity at human MC1R expressed in HEK2936E cells assessed as cAMP production in presence of IBMX by time resolved fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
PubMed
TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM50590040(CHEMBL5185945)
Affinity DataEC50: >0.00912nMAssay Description:Agonist activity at human MC1R expressed in HEK2936E cells assessed as cAMP production in presence of IBMX by time resolved fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2023
Entry Details
PubMed
TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250653(US9447148, 9.22)
Affinity DataKi:  0.0100nM ΔG°:  -65.3kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250652(US9447148, 9.21)
Affinity DataKi:  0.0100nM ΔG°:  -65.3kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM50250586(CHEMBL4093140)
Affinity DataEC50:  0.0100nMAssay Description:Displacement of [125I]-NDP-alpha-MSH from human MC1R expressed in HEK293 cells after 40 mins by gamma counting methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2019
Entry Details Article
PubMed
TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM50250586(CHEMBL4093140)
Affinity DataIC50: 0.0100nMAssay Description:Displacement of [125I]-NDP-alpha-MSH from human MC1R expressed in HEK293 cells after 40 mins by gamma counting methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2019
Entry Details Article
PubMed
TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250633(US9447148, 9.1)
Affinity DataKi:  0.0100nM ΔG°:  -65.3kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM50301155(Ph(CH2)3CO-His-D-Phe-Arg-Trp-NH2 | CHEMBL569693)
Affinity DataEC50:  0.0100nMAssay Description:Agonistic activity against human MC1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/26/2012
Entry Details Article
PubMed
TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250645(US9447148, 9.13)
Affinity DataEC50:  0.0100nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250642(US9447148, 9.10)
Affinity DataKi:  0.0100nM ΔG°:  -65.3kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250634(US9447148, 9.31 | US9447148, 9.2)
Affinity DataKi:  0.0120nM ΔG°:  -64.8kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250647(US9447148, 9.15)
Affinity DataEC50:  0.0120nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250638(US9447148, 9.6)
Affinity DataEC50:  0.0140nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250668(US9447148, 9.50 | US9447148, 9.37)
Affinity DataKi:  0.0140nM ΔG°:  -64.4kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250668(US9447148, 9.50 | US9447148, 9.37)
Affinity DataKi:  0.0140nM ΔG°:  -64.4kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

Displayed 1 to 50 (of 1827 total ) | Next | Last >>
Jump to: